DK1594456T3 - Anvendelse af en sammensætning indeholdende vitamin K1-oxid eller et derivat deraf til behandling og/eller forebyggelse af dermatologiske læsioner hos pattedyr - Google Patents
Anvendelse af en sammensætning indeholdende vitamin K1-oxid eller et derivat deraf til behandling og/eller forebyggelse af dermatologiske læsioner hos pattedyrInfo
- Publication number
- DK1594456T3 DK1594456T3 DK04703319T DK04703319T DK1594456T3 DK 1594456 T3 DK1594456 T3 DK 1594456T3 DK 04703319 T DK04703319 T DK 04703319T DK 04703319 T DK04703319 T DK 04703319T DK 1594456 T3 DK1594456 T3 DK 1594456T3
- Authority
- DK
- Denmark
- Prior art keywords
- derivative
- oxide
- mammals
- treating
- composition containing
- Prior art date
Links
- KUTXFBIHPWIDJQ-BTPXSFBUSA-N (1ar,7as)-7a-methyl-1a-[(e,7r,11r)-3,7,11,15-tetramethylhexadec-2-enyl]naphtho[2,3-b]oxirene-2,7-dione Chemical compound O=C1C2=CC=CC=C2C(=O)[C@@]2(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@]1(C)O2 KUTXFBIHPWIDJQ-BTPXSFBUSA-N 0.000 title abstract 3
- 241000124008 Mammalia Species 0.000 title abstract 2
- 230000003902 lesion Effects 0.000 title abstract 2
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 title 1
- 239000003581 cosmetic carrier Substances 0.000 abstract 2
- 239000002537 cosmetic Substances 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 150000003904 phospholipids Chemical class 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B1/00—Nanostructures formed by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Nanotechnology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Birds (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Obesity (AREA)
- Nutrition Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Toxicology (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US31988703P | 2003-01-20 | 2003-01-20 | |
| EP03447019A EP1442738A1 (en) | 2003-01-28 | 2003-01-28 | Dermatological cosmetic composition comprising vitamin K1 oxide |
| PCT/BE2004/000011 WO2004064798A1 (en) | 2003-01-20 | 2004-01-20 | Use of a composition comprising vitamin k1 oxide or a derivative thereof for the treatment and/or the prevention of mammal dermatological lesions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1594456T3 true DK1594456T3 (da) | 2009-01-19 |
Family
ID=32773677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04703319T DK1594456T3 (da) | 2003-01-20 | 2004-01-20 | Anvendelse af en sammensætning indeholdende vitamin K1-oxid eller et derivat deraf til behandling og/eller forebyggelse af dermatologiske læsioner hos pattedyr |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7939568B2 (da) |
| EP (1) | EP1594456B1 (da) |
| JP (1) | JP2006515873A (da) |
| KR (1) | KR20050103906A (da) |
| CN (1) | CN100531727C (da) |
| AT (1) | ATE406868T1 (da) |
| CA (1) | CA2513324C (da) |
| DE (1) | DE602004016292D1 (da) |
| DK (1) | DK1594456T3 (da) |
| ES (1) | ES2314365T3 (da) |
| PT (1) | PT1594456E (da) |
| SI (1) | SI1594456T1 (da) |
| WO (1) | WO2004064798A1 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2885802A1 (fr) * | 2005-05-17 | 2006-11-24 | Oreal | Utilisation cosmetique de la vitamine k pour ameliorer la fonction barriere de la peau |
| US8003839B2 (en) | 2006-02-03 | 2011-08-23 | Exxonmobil Chemical Patents Inc. | Process for generating linear apha olefin comonomers |
| US8076524B2 (en) | 2006-02-03 | 2011-12-13 | Exxonmobil Chemical Patents Inc. | Process for generating alpha olefin comonomers |
| US20100130618A1 (en) * | 2007-07-24 | 2010-05-27 | Viridis Biopharma Pvt. Ltd. | Treatment of human disease conditions and disorders using vitamin k analogues and derivatives |
| US20160152398A1 (en) * | 2013-07-01 | 2016-06-02 | Meiji Co., Ltd. | Method for improving photostability of food and beverage products |
| US9421297B2 (en) | 2014-04-02 | 2016-08-23 | Adhezion Biomedical, Llc | Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB744376A (en) | 1952-03-08 | 1956-02-08 | Merck & Co Inc | Vitamin emulsions |
| US3070499A (en) * | 1960-09-19 | 1962-12-25 | Merck & Co Inc | Parenteral aqueous solutions of fat soluble vitamins |
| JPH05320039A (ja) * | 1991-09-20 | 1993-12-03 | Taiyo Kagaku Co Ltd | 美白化粧料 |
| DE69333575T2 (de) * | 1992-05-28 | 2005-08-25 | Centre For Molecular Biology And Medicine, Richmond | Quinone-derivate zur verbesserung der zellulare bioenergie |
| DE69331727D1 (de) | 1992-06-30 | 2002-04-25 | Howard K Shapiro | Verwendung einer kombination bestehend aus einem aminderivat oder aminverwandten derivat der benzoesäure und einem amino-polysaccharide zur herstellung eines medikaments fuer die behandlung von entzündlichen erkrankungen |
| US5510391A (en) * | 1993-10-22 | 1996-04-23 | Mayapple Holdings, Llc | Method of treating blood vessel disorders of the skin using vitamin K |
| US5540934A (en) * | 1994-06-22 | 1996-07-30 | Touitou; Elka | Compositions for applying active substances to or through the skin |
| US5945409A (en) * | 1995-03-10 | 1999-08-31 | Wilson T. Crandall | Topical moisturizing composition and method |
| WO1997039746A1 (en) | 1996-04-22 | 1997-10-30 | Advanced Polymer Systems, Inc. | Method of and composition for treating disorders of the skin using vitamin k |
| US6180136B1 (en) * | 1998-11-10 | 2001-01-30 | Idexx Laboratories, Inc. | Phospholipid-coated microcrystals for the sustained release of pharmacologically active compounds and methods of their manufacture and use |
-
2004
- 2004-01-20 KR KR1020057013381A patent/KR20050103906A/ko not_active Withdrawn
- 2004-01-20 SI SI200430948T patent/SI1594456T1/sl unknown
- 2004-01-20 WO PCT/BE2004/000011 patent/WO2004064798A1/en not_active Ceased
- 2004-01-20 US US10/542,914 patent/US7939568B2/en not_active Expired - Lifetime
- 2004-01-20 AT AT04703319T patent/ATE406868T1/de active
- 2004-01-20 JP JP2006500422A patent/JP2006515873A/ja active Pending
- 2004-01-20 DK DK04703319T patent/DK1594456T3/da active
- 2004-01-20 CA CA2513324A patent/CA2513324C/en not_active Expired - Fee Related
- 2004-01-20 EP EP04703319A patent/EP1594456B1/en not_active Expired - Lifetime
- 2004-01-20 CN CNB2004800024903A patent/CN100531727C/zh not_active Expired - Fee Related
- 2004-01-20 DE DE602004016292T patent/DE602004016292D1/de not_active Expired - Lifetime
- 2004-01-20 PT PT04703319T patent/PT1594456E/pt unknown
- 2004-01-20 ES ES04703319T patent/ES2314365T3/es not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP1594456B1 (en) | 2008-09-03 |
| WO2004064798A1 (en) | 2004-08-05 |
| ATE406868T1 (de) | 2008-09-15 |
| CN100531727C (zh) | 2009-08-26 |
| PT1594456E (pt) | 2008-12-16 |
| US20060154983A1 (en) | 2006-07-13 |
| DE602004016292D1 (de) | 2008-10-16 |
| KR20050103906A (ko) | 2005-11-01 |
| HK1087010A1 (zh) | 2006-10-06 |
| US7939568B2 (en) | 2011-05-10 |
| CA2513324A1 (en) | 2004-08-05 |
| SI1594456T1 (sl) | 2009-02-28 |
| CA2513324C (en) | 2010-09-21 |
| JP2006515873A (ja) | 2006-06-08 |
| CN1738594A (zh) | 2006-02-22 |
| ES2314365T3 (es) | 2009-03-16 |
| EP1594456A1 (en) | 2005-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20050795L (no) | Forbindelser, blandinger og fremgangsmater for utnyttelse av samme | |
| BR0313176A (pt) | Composições de pirazol úteis como inibidores de gsk-3 | |
| NO20055863L (no) | W-karboksyarylsubstituerte difenylureaforbindelser som raf-kinaseinhibitorer | |
| CY1105349T1 (el) | Θειαζολυλ-αναστολεις τυροκινασεων της οικογενειας tec | |
| BR0308243A (pt) | Composto, formulação farmacêutica, e, métodos de tratar diabetes, doença de alzheimer, e de inibir gsk-3 em um mamìfero | |
| BR0316350A (pt) | Diaminotriazóis úteis como inibidores de proteìna cinases | |
| BRPI0418251B8 (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo | |
| BR0207961A (pt) | Combinação de análogos da epotilona e agentes quimioterápicos para o tratamento de doenças proliferativas | |
| TR200101481T2 (tr) | Doğal bitkisel zaruri yağlar kullanan kanser tedavi kompozisyonu ve yöntemi. | |
| BR0209127A (pt) | compostos, composições farmacêuticas, métodos para o tratamento de dores, métodos para a modulação de uma resposta farmacológica e usos de compostos | |
| UY26130A1 (es) | Compuestos para tratar la obesidad | |
| EA200400689A1 (ru) | Фармацевтические и косметические композиции, содержащие ароматические альдегиды, содержащие оксигруппу | |
| DE60140871D1 (de) | Arylmethylamin-derivate zur verwendung als inhibitoren von tryptase | |
| BRPI0517435A (pt) | triazóis úteis como inibidores de proteìna cinase | |
| DK0832081T3 (da) | Bicykliske-aromatiske forbindelser | |
| ES2163735T3 (es) | Compuestos biarilos heterociclicos, composiciones farmaceuticas y cosmeticas que los contienen y utilizaciones. | |
| BR0201862A (pt) | Composições e métodos para tratar ou prevenir convulsões ou ataques apoplécticos | |
| AR020563A1 (es) | Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion | |
| NO20073575L (no) | Farmasoytiske sammensetninger for behandling av cellulitt | |
| ATE223376T1 (de) | Bisarylcyclobutenderivate als cyclooxygenasehemmer | |
| PA8525801A1 (es) | Compuestos de pirazol, composiciones farmacéuticas, y métodos para modular y/o inhibir la actividad de erab/hadh2 | |
| ES2147973T3 (es) | Estirenos alquilatados como profarmacos de inhibidores de cox-2. | |
| NO983511D0 (no) | Difenylstilbener som pro-legemidler for COX-2-inhibitorer | |
| TR200302134T4 (tr) | 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı. | |
| BR0010255A (pt) | Formulação farmacêutica, kit de partes, método para tratamento de um paciente sofrendo de ou susceptìvel a uma condição em que a inibição da trombina e/ou inibição da carboxipeptidase u são requeridas ou desejadas, e, uso de uma formulação |